Stock Picks: Bristol-Myers Squibb, Clarient, Dell, eBay

Bristol-Myers Squibb Co.: Leerink Swann equity analyst Seamus Fernandez raised a rating on shares of Bristol-Myers Squibb Co. (BMY) to outperform from market perform on June 11. He raised a discounted cash flow-based valuation range on the shares to $28 to $29 from $23 to $24.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.